With Berkshire Hathaway disclosing their holdings in their latest 2nd quarter 13-F, I thought it would be interesting to go through each position that is held and calculate the stock value in hopes of gaining some ideas.
Going through portfolio’s of respected investors is another way of generating ideas. Davy Bui of The Enlightened American does a fine job of tracking and displaying hedge fund holdings of respected investors in an easy to read format.
There are 41 positions in the portfolio of Warren Buffett and Berkshire so I’ll be breaking it up over numerous posts.
(Download the free E-Book format of Warren Buffett Stocks Series)
Although I’ll try to put a value on each company, except financials, there are industries that are outside of my circle of competence which I may calculate incorrectly.
E.g. I don’t know much about pharmaceuticals and commodities and how to look at these businesses as a future going concern which will make it difficult to apply a growth rate that I would be comfortable with compared to others.
Going through the first 10 Stock Ideas
(Current stock prices vary due to timing of writing)
Becton, Dickinson and Company (BDX) is a medical technology company that operates through three business segments: BD Medical, BD Diagnostics, and BD Biosciences.

BDX Spider Graph
(The above graph is from an analysis of BDX which is posted at Dividend Growth Investor.)
DCF Stock Value: $87
Graham Stock Value: $110
Competitor and Peer Comparison: $76

BDX Price vs Value Graph
Burlington Northern Santa Fe is a holding company and engaged primarily in the freight rail transportation business.
DCF Stock Value: $87
Graham Stock Value: $145
Competitor and Peer Comparison: $76

BNI Price vs Value Graph
The Company is a retailer of used cars.
DCF Stock Value: N/A
Graham Stock Value: $11 – $15
Competitor and Peer Comparison: N/A
Can’t seem to get within an acceptable fair value range on CarMax.
Thin margins, cyclical, inconsistent with low returns. Not quite sure how this position fits in. Definitely doesn’t look like a Buffett pick.
No introduction needed.
DCF Stock Value: $38 – $44
Graham Stock Value: $61
Competitor and Peer Comparison: Looks fairly valued

KO Price & Value Graph
Comcast Corporation is a provider of cable TV, internet and phone services.
DCF Stock Value: N/A
Graham Stock Value: $22
Competitor and Peer Comparison: $12.48

CMCSA Graham Formula
Simply put, CDCO is a liquidation special situation.
Using Ben Graham Net Net Spreadsheet, the liquidation value looks to be worth $8.38 while the current price is at $7.50. With most of the assets in cash, this would have been a pretty good liquidation play had the spread been wider.
Since the company emerged from bankruptcy in 2002, it doesn’t seem like CDCO is in a hurry to sell the remaining assets.
With real liquidations involving some fees, the current 11% margin of safety isn’t big enough to take a bite for an investor like myself.
Net Net Working Capital value: $8.38

CDCO Ben Graham Net Net Value
The investment which Buffett admits he made a mistake for buying at too high a price.
DCF Stock Value: $64 adjusted to normalize a terrible year
Graham Stock Value: N/A
Competitor and Peer Comparison: Looks to be on par with competitors
In it’s current state, COP doesn’t look like a good hold.
An excellent analysis and description of Costco (COST), its operations and valuation by Brad of TMWTFS.
DCF Stock Value: $39
Graham Stock Value: $47 looks to be the upper limit
Competitor and Peer Comparison: More expensive than WMT. Should be around $37 based on competition.
Some obvious Buffett stock picks in this list while several seem to have been by other managers.
Took quite a while to get this all together but I hope you are getting some ideas as well how I quickly look at companies to filter what I deem to be the good from the bad.
- Fabrice
Nice article and new Website look is terrific.
Very good job Jae Jun. Keep going!
- Jae Jun
Hi Fabrice,
Appreciate the comment. Thanks!
- KenC
Pretty sure Carmax is a Lou Simpson position (Capital Allocator at Geico) as is BAC. Geico is the only subsidiary that is allowed to make its own investments.
.-= KenC´s last blog ..Buffett: Don’t hate the player, hate the game =-.
- Davy Bui
Hey Jae,
Thanks for the shout out. Funny enough, I cover all the big names except for Warren Buffet; Berkshire’s 13F is formatted differently than everyone else’s and I’m too lazy to do it manually. Besides, sites like Old School Value have the Buffett tip well-covered. Like Munger says, I’ve got nothing to add.
I have to second the positive comment on the site redesign — it looks fantastic!
Great post, too, btw. I’ll have to take a look at BDX.
.-= Davy Bui´s last blog ..Seth Klarman, Marty Whitman & David Einhorn 2009 Q2 13F Filings =-.
- Jae Jun
@ KenC,
I agree that Simpson is the purchaser of CarMax but didn’t know that he was the only one allowed to make individual investments. Will have to look into that.
Thanks.
@ Davy,
Just giving a fellow investor and site where I get ideas due respect.
I looked Seth Klarman’s positions yesterday and wasn’t surprised to see there wasn’t much action taking place in the last quarter.
Will have to read up on Einhorn considering he sold his gold positions.
- rupneu1
Thanks for the analysis of the companies. Actually, I am an end user of most of the BDX products and our company is probably one of their significant customer. Even before Buffet’s holdings were released, I was looking at BDX since I know the field pretty well and know that BD has significant “moat” on this field. However, I haven’t bought BDX because I thought it was fairy valued around $70-75. i guess it did go down to $58 at some point, and would have been a good buy.
.-= rupneu1´s last blog ..Warren Buffet buys more J&J =-.
- KenC
@ Jae Jun,
I have read so many Buffett related books and articles I can’t tell you specifically where I read it. But I believe it to be a pretty well known fact that Geico is the only part of BRK that does its own capital allocation. I will see if I can dig up an precise reference.
.-= KenC´s last blog ..Buffett: Don’t hate the player, hate the game =-.
- 4cinvestor
Hi Jae,
Excellent Work.
BTW, did you notice that in BRK, stock picks has only around 19% of the total book value ( check 2008 annual report)?
This can mean that the value of BRK should not be strongly impacted by those public companies performance.
- Jae Jun
@rupneu1,
Do let me know if my short analysis is incorrect on BDX
@KenC,
I’ll take your word for it
@4cinvestor,
Thanks. I didn’t compare the stock value holdings to the total book value but considering how many companies make up Berkshire, especially Geico, it does seem like a small portion.
Buffett also has a lot of derivatives and other investments that are listed in the 13-F which would have added to his performance.
- Hanna
Jae, I feel so lucky that I found your website through another investment blog. What can I say about your investment spreadsheet toolkit? one word: brilliant!
- Jae Jun
Thanks Hanna!
Glad you are finding the spreadsheet helpful and easy to use.
Email me anytime with additional questions.
- Tyler
what about BYD.DF
- Jae Jun
Sorry but I dont invest or look into gambling related stocks so I dont have anything to offer for BYD.
Write up requests in the forum section. It’ll make it easier to track and keep it focused.
- investor
The KO intrinsic value is a tad high, dont you think?
I calculated it and got much lower IV:
Walk through
If we assume initial earnings of $5.8B grow at a rate of 10.28%, and we discount those future earnings at a rate of 15.00%, we arrive at IV of $47.06. To account for potential earnings beyond the 10th year, we estimate a growth rate of 6.00%, a discount rate of 12.00%. (using quicken.com valuation tool)
- Jae Jun
Which intrinsic value do you see as the high one? The DCF or Graham?
I assume it is the Graham one because the DCF I have is in the 40’s as well.
Since the Graham formula uses earnings, it is likely to be higher.
- investors
Hi Jae,
Regarding your question:
I do believe it is Graham’s.
You can see the full analysis here: it is free to register (you can enter whatever info. you want as there is no email check):
http://investing.quicken.com/research/evaluator.asp?symbol=ko
- Jae Jun
I didn’t know that Quicken provided a calculator. Real cool. Thanks a lot. I’ll add it to my list.
When I compared my DCF with the Quicken one using the same growth rate of 8.93%, starting with a FCF value of $5.8b, but I used a 9% discount rate as I do for all stable blue chips, I get a DCF intrinsic value of $42.75.
Compared to Quicken’s $42.45 it is the same.
Now my question is do you expect to get a 15% or 9% return from KO annually?
- frank
Hi Jae,
I thought I would take a chance on Insm when you went in at 0.85
(as a newbie)
The price is now 1.05 with a target price of $2.00 (I think I saw in S&P)
I do not see it in your portfolio here. Do you still have it.
What has attributed to the raise in price other then possible lift from being a health stock and having good cash position to keep it going.
I like your approach to stock investing and read every thing I can find on Warren Buffet.
Keep writing those great articles,
they are very good.
Thank you,
Frank
- Jae Jun
Hi Frank,
This portfolio is an analysis of Buffett’s portfolio, not mine.
Also, don’t trust the S&P. They have no idea what is going on with INSM.
But here is the news that leaked out.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=46695692
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=46820292
I also believe that Merck is very interested in INSM. While INSM have insinuated that they prefer a reverse merger, with the way things are going and how Merck is mentioning INSM in their conferences, looks to be a great opportunity.